Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone.

Jian WangXiaomin YanLi ZhuJiacheng LiuYuanwang QiuYiguang LiYilin LiuRuifei XueJie ZhanSuling JiangYu GengYawen WanMing LiMinxin MaoDongmei GaoShengxia YinXin TongJuan XiaWeimao DingYuxin ChenJie LiChuanwu ZhuRui Huang Chao Wu

Published in: Alimentary pharmacology & therapeutics (2022)

Over 70% of GZ CHB patients had significant histological disease. We recommend antiviral treatment for HBeAg-positive and HBeAg-negative GZ CHB patients with high PT.

Keyphrases

hepatitis b virus
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
white matter
combination therapy
replacement therapy